BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/9/2022 12:48:14 PM | Browse: 266 | Download: 701
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 74238
Country/Territory China
Received
2021-12-29 13:36
Peer-Review Started
2021-12-29 13:38
To Make the First Decision
Return for Revision
2022-04-17 01:23
Revised
2022-05-13 13:43
Second Decision
2022-07-21 03:10
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2022-07-26 18:30
Articles in Press
2022-07-26 18:30
Publication Fee Transferred
Edit the Manuscript by Language Editor
2022-07-17 03:41
Typeset the Manuscript
2022-07-29 11:55
Publish the Manuscript Online
2022-09-09 12:48
ISSN 1948-5204 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Review
Article Title Advances in postoperative adjuvant therapy for primary liver cancer
Manuscript Source Unsolicited Manuscript
All Author List Zhi-Ming Zeng, Ning Mo, Jie Zeng, Fu-Chao Ma, Yan-Feng Jiang, Hua-Sheng Huang, Xi-Wen Liao, Guang-Zhi Zhu, Jie Ma and Tao Peng
ORCID
Author(s) ORCID Number
Zhi-Ming Zeng http://orcid.org/0000-0002-5115-5411
Ning Mo http://orcid.org/0000-0002-3698-4561
Jie Zeng http://orcid.org/0000-0002-8582-7319
Fu-Chao Ma http://orcid.org/0000-0003-1248-1713
Yan-Feng Jiang http://orcid.org/0000-0001-7168-7071
Hua-Sheng Huang http://orcid.org/0000-0003-1112-5071
Xi-Wen Liao http://orcid.org/0000-0002-1724-1463
Guang-Zhi Zhu http://orcid.org/0000-0001-5958-7289
Jie Ma http://orcid.org/0000-0002-9907-7133
Tao Peng http://orcid.org/0000-0001-6133-7078
Funding Agency and Grant Number
Corresponding Author Tao Peng, MD, PhD, Chief Doctor, Professor, Surgeon, Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, No. 6 Shuang Yong Road, Qingxiu District, Nanning 530021, Guangxi Zhuang Autonomous Region, China. pengtaogmu@163.com
Key Words Adjuvant therapy; Liver cancer; Immunotherapy; Chemotherapy; Targeted therapy
Core Tip This review discusses the risk factors for recurrence in patients with hepatocellular carcinoma (HCC) radical surgical resection and adjuvant treatment options that may reduce the risk of recurrence and improve overall survival, including local adjuvant therapy (e.g., transcatheter arterial chemoembolization), adjuvant systemic therapy (e.g., molecular targeted agents), and other adjuvant therapies (e.g., antiviral and herbal therapy). Finally, potential research directions that may change the paradigm of adjuvant therapy for HCC are analyzed.
Publish Date 2022-09-09 12:48
Citation Zeng ZM, Mo N, Zeng J, Ma FC, Jiang YF, Huang HS, Liao XW, Zhu GZ, Ma J, Peng T. Advances in postoperative adjuvant therapy for primary liver cancer. World J Gastrointest Oncol 2022; 14(9): 1604-1621
URL https://www.wjgnet.com/1948-5204/full/v14/i9/1604.htm
DOI https://dx.doi.org/10.4251/wjgo.v14.i9.1604
Full Article (PDF) WJGO-14-1604.pdf
Full Article (Word) WJGO-14-1604.docx
Manuscript File 74238_Auto_Edited-LM.docx
Answering Reviewers 74238-Answering reviewers.pdf
Audio Core Tip 74238-Audio core tip.mp4
Conflict-of-Interest Disclosure Form 74238-Conflict-of-interest statement.pdf
Copyright License Agreement 74238-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate 74238-Language certificate.pdf
Peer-review Report 74238-Peer-review(s).pdf
Scientific Misconduct Check 74238-CrossCheck.png
Scientific Misconduct Check 74238-Bing-Gong ZM-2.png
Scientific Editor Work List 74238-Scientific editor work list.pdf